Table 3 Reasons for SMC drugs having no NICE designation for EOL
Number of submissions | |
|---|---|
No NICE appraisal: | |
In development | 10 |
Suspended | 2 |
Non-submission by the company | 2 |
Not scheduled for NICE appraisal | 2 |
NICE agreed to fund without EOL consideration | 3 |
NICE ICER too high regardless of EOL status | 2 |
Appraised by NICE pre-2009 (ie before introduction of EOL criteria) | 1 |
Total | 22 |